Viewing Study NCT00228020


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-06-05 @ 6:36 PM
Study NCT ID: NCT00228020
Status: COMPLETED
Last Update Posted: 2010-08-25
First Post: 2005-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CCHI621ADE01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Novartis
Old Organization: Novartis

Collaborators